Skip to main navigation
tlc tlc
  • About
    • Company Overview
    • History
    • Management
    • Board of Directors
    • Audit Committee
    • Corporate Responsibility
      • Social Responsibility
      • Sustainable Environment
      • Corporate Philanthropy
      • Codes of Ethics
  • Pipeline
    • Overview
    • Pain Management
      • TLC599
      • TLC590
    • Ophthalmology
      • TLC399
    • Oncology
      • TLC178
    • Infectious Diseases
      • Ampholipad™
      • ISPM19
  • Technology
    • Sustained Release
      • BioSeizer™
    • Targeted Delivery
      • NanoX™
      • Antibody-Linked Nanomedicines
    • Other Technologies
      • Polymeric Micelle
  • Investors
    • Corporate Info
      • Company Profile
      • Management
      • IR Contact
    • News & Events
      • Press Releases
      • Events & Presentations
    • Filings
  • Pressroom
    • Press Releases
    • Media Library
    • Publications
  • Careers
    • Benefits
    • Job Opportunities
  • Contact Us
  • Contact Us
  • Language
    • English
    • 繁體中文
    • 日本語
Home investor overview

Investors

Investor

Financial Statements
2021 Q2 Consolidated Financial Statements
2021 Q1 Consolidated Financial Statements

View All Reports

Stock Information

Stock Market in Details

Latest News
Date Title
2022-06-13 TLC Announces TLC599 Agreement with Endo
2022-03-07 TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

More Press Releases

Upcoming Events
There are currently no events scheduled.

Events and Presentations

FAQ Link

Investors FAQs

Get answers to frequently asked questions

corporate information

Corporate Information

A look at our Company Profile and Corporate Governance

Learn More

Website Notice Block

  RSS Feeds
  IR Contacts
  Print Page
  • About
    • Company Overview
    • History
    • Management
    • Board of Directors
    • Audit Committee
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Pain Management
    • Ophthalmology
    • Oncology
    • Infectious Diseases
  • Technology
    • Sustained Release
    • Targeted Delivery
    • Other Technologies
  • Investors
    • Corporate Info
    • News & Events
    • Filings
  • Pressroom
    • Press Releases
    • Media Library
    • Publications
  • Careers
    • Benefits
    • Job Opportunities
  • Contact Us
tlc
E-mail Alerts
Terms of Use | Privacy Policy © 2018-2023 Taiwan Liposome Company, Ltd. All rights reserved.